The Global Fund raised $12.64 billion, a third short of what it asked for

The Global Fund to Fight AIDS, Tuberculosis and Malaria raised US$12.64 billion in its Eighth Replenishment, its board confirmed on 18 February, roughly 70% of the US$18 billion its own Investment Case said was needed to keep the three diseases in retreat [s1][s2]. The result is the money the partnership will have to work with for the 2027-2029 grant cycle, and it lands about a third below the target the Fund set itself.

On the basis of that US$12.64 billion in total pledges, the board approved US$10.78 billion in grant allocations to countries for the 2026-2028 implementation period, alongside US$260 million for catalytic investments, with a further US$306 million in private-sector funding earmarked for catalytic work as that fundraising continues [s1]. Executive Director Peter Sands called it a "remarkable result, achieved in a challenging global context," while the board itself "underscored that funding gaps threaten progress toward ending the three diseases" [s1].

What the $18 billion was for

The Investment Case, published a year earlier, is explicit about what the full ask would buy. With US$18 billion, the Global Fund estimated it could help save 23 million additional lives and prevent 400 million infections or cases across HIV, tuberculosis and malaria, cutting the combined annual death toll in the countries it supports from 2.3 million in 2023 to 920,000 in 2029 — a 64% reduction in the mortality rate relative to 2023 levels [s2]. Those are modelled targets contingent on the money arriving and on other funders holding their lines, not guarantees, and the Fund frames them as what is achievable rather than what is assured [s2].

The US$18 billion was never meant to cover the whole bill. The Investment Case puts the total resource need for the three-disease response in Global Fund-supported countries at US$140.6 billion for 2027-2029 [s2]. Of that, domestic resources are expected to cover US$69.7 billion (50%) and non-Global Fund external financing US$23.6 billion (17%), with the Global Fund itself contributing US$18 billion (13%) — leaving an unfunded gap of US$29.4 billion, or 21% of the need [s2]. A replenishment that comes in a third short does not shrink that gap; it widens it, because the US$18 billion slice was already the smallest of the funded components.

The summit and the shortfall

The pledging summit was held in Johannesburg in November 2025 on the margins of the G20 Leaders' Summit, the first Global Fund replenishment ever hosted on African soil, co-hosted by South Africa and the United Kingdom [s3][s1]. It drew the first pledge from an African government to the Fund — a US$3 million contribution from Uganda — as part of a push to frame the partnership as shared responsibility rather than charity [s3]. Pledges continued to arrive afterward: Saudi Arabia added US$39 million in late January 2026, and private-sector mobilisation is still open [s1].

Even so, the total fell well below the previous replenishment's level and below the target, in a period when several of the Fund's largest historical donors have been cutting external aid. The board's response was to change how the smaller sum is spent rather than to pretend it is enough.

The strategic shift

Alongside the funding decision, the board endorsed a set of "strategic shifts" first floated at the end of 2025: concentrating grant money on the least-resourced, highest-burden countries and pushing better-off recipients toward financing their own programmes faster [s1]. "Supporting countries to transition away from Global Fund support is not new; what is new is the scale and pace of transition we are now driving," Sands said, describing a plan to work with countries and "ultimately, getting out of the way" [s1].

That is a rational way to ration a shortfall, but it also transfers risk to national budgets that the Investment Case already expected to carry half the total need [s2]. The stakes of getting the transition wrong are visible in the Fund's own illustration: in Zambia, life expectancy rose from 43 years in 2002 to 58 years in 2021, and more than two-thirds of that gain is attributed to fewer people dying of AIDS, TB and malaria [s2]. Whether gains like that hold as external money thins is the question the next three years will answer.

Sources

• [s1] Global Fund Board Welcomes Final Eighth Replenishment Outcome of US$12.64 Billion, The Global Fund, 18 February 2026. https://www.theglobalfund.org/en/news/2026/2026-02-18-global-fund-board-welcomes-final-eighth-replenishment-outcome/
• [s2] Global Fund Eighth Replenishment Investment Case (Summary), The Global Fund, 10 February 2025. https://www.theglobalfund.org/media/15381/core_2025-investment-case_summary_en.pdf
• [s3] African Diplomats Reaffirm Unwavering Commitment to Global Health Support Ahead of Replenishment Summit, The Global Fund, 17 November 2025. https://www.theglobalfund.org/en/news/2025/2025-11-17-african-diplomats-reaffirm-unwavering-commitment-global-health-support-replenishment/